铁元素与子宫颈癌的关系
Relation of Iron and Cervical Cancer

作者: 陈东祥 :长江大学附属第一医院,荆州; 徐元屏 :湖北省中医药高等专科学校,荆州;

关键词: 子宫颈癌Iron Cervical Cancer

摘要:

铁是细胞生长的必需元素,肿瘤细胞内铁的含量高于正常细胞。增加外源性的铁元素可以防止细胞凋亡,而铁螯合剂可以抑制肿瘤细胞生长。因此,铁螯合剂在抗肿瘤方面受到日益广泛的关注。近年来研究表明,铁与子宫颈癌细胞的增殖和凋亡有着密切关系,对此,本文探讨了铁元素在子宫颈癌发生中的作用机制及铁螯合剂在治疗宫颈癌方面的作用。

Abstract:  Iron is an essential element for cell growth. The iron contents in tumor cells are higher than those in normal cells. The addition of exogenous iron can prevent apoptosis while iron chelators can inhibit the growth of tumor cells. Therefore, the anti-tumor effect of iron chelators obtains more and more extensive concern. This article aims to present a review on recent advancements in studies of iron and cervical cancer, and to explore the mechanism of iron in initiating cervical cancer as well as the effects of iron chelators on treatment of cervical cancer.

文章引用: 陈东祥 , 徐元屏 (2014) 铁元素与子宫颈癌的关系。 世界肿瘤研究, 4, 1-3. doi: 10.12677/WJCR.2014.41001

参考文献

[1] Hann, H.W., Stahlhut, M.W. and Menduke, H. (1991) Iron en- hances tumor growth. Observation on spontaneous mammary tumors in mice. Cancer, 68, 2407-2410.

[2] Hann, H.W., Stahlhut, M.W. and Blumberg, B.S. (1988) Iron nutrition and tumor growth: Decreased tumor growth in iron- deficient mice. Cancer Research, 48, 4168-4170.

[3] Drakesmith, H. and Prentice, A. (2008) Viral infection and iron metabolism. Nature Reviews Microbiology, 6, 541-552.

[4] Stevens, R.G., Jones, D.Y., Micozzi, M.S., et al. (1988) Body iron stores and the risk of cancer. New England Journal of Med- icine, 319, 1047-1052.

[5] Huang, X. (2003) Iron overload and its association with cancer risk in humans: Evidence for iron as a carcinogenic metal. Mu- tation Research, 533, 153-171.

[6] Richardson, D.R., Kalinowski, D.S., Lau S., et al. (2009) Cancer cell iron metabolism and the development of potent iron chela- tors as anti-tumour agents. Biochimica et Biophysica Acta, 1790, 702-717.

[7] Huang, X., Dai, J., Fournier, J., et al. (2002) Ferrous ion autoxi- dation and its chelation in iron-loaded human liver HepG2 cells. Free Radical Biology & Medicine, 32, 84-92.

[8] Palmer, H.J. and Paulson, K.E. (1997) Reactive oxygen species and antioxidants in signal transduction and gene expression. Nu- trition Reviews, 55, 353-361.

[9] Siegel, E.M., Patel, N., Lu, B., et al. (2012) Circulating bio- markers of iron storage and clearance of incident human papil- lomavirus infection. Cancer Epidemiology, Biomarkers & Pre- vention, 21, 859-865.

[10] 顾庆, 杨朝晖, 薛金玲等 (2007) 晚期宫颈癌患者在动脉介入化疗前后血清铁含量变化的探讨. 河北医学, 13, 383-385.

[11] 吴国芳, 李青旺, 李健等 (2009) 人乳铁蛋白对宫颈癌Hela细胞凋亡的影响. 黑龙江畜牧兽医(科技版), 11, 70.

[12] Radha, K.S., Sugiki, M., Yoshida, E., et al. (2005) Iron-mediated stability of PAI-1 mRNA in adenocarcinoma cells-involvement of a mRNA-binding nuclear protein. Thrombosis Research, 116, 255-263.

[13] Drakesmith, H. and Prentice, A. (2008) Viral infection and iron metabolism. Nature Reviews Microbiology, 6, 541-555.

[14] Eaton, J.W. and Qian, M. (2002) Molecular bases of cellular iron toxicity. Free Radical Biology & Medicine, 32, 833-840.

[15] 吴训贤 (1992) 铁摄入过量对健康影响. 国外医学医学地理分册, 13, 100.

[16] Weinberg, E.D. (1983) Iron in neoplastic disease. Nutrition Can- cer, 4, 223-233.

[17] Potischman, N. and Brinton, L.A. (1996) Nutrition and cervical neoplasia. Cancer Causes Control, 7, 113-126.

[18] Pham, C.G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alva- rez, K., et al. (2004) Ferritin heavy chain upregulation by NF- kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell, 119, 529-542.

[19] Poljak-Blazi, M., Jaganjac, M., Sabol, I., et al. (2011) Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. Toxicology in Vitro, 25, 160-166.

[20] Simonart, T., Boelaert, J.R., Mosselmans, R., et al. (2002) Anti- proliferative and apoptotic effects of iron chelators on human- cervical carcinoma cells. Gynecologic Oncology, 85, 95-102.

[21] Simonart, T., Boelaert, J.R., Andrei, G., et al. (2003) Iron with- drawal strategies fail to prevent the growth of SiHa-induced tu- mors in mice. Gynecologic Oncology, 90, 91-95.

[22] Takahiro, Y., Shuji, T., Isao, S., et al. (2011) Deferoxamine for advanced hepatocellular carcinoma. New England Journal of Medicine, 365, 576-578.

分享
Top